118 related articles for article (PubMed ID: 29531172)
21. Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells.
Wang J; Lau KY; Jung J; Ravindran P; Barrat FJ
Eur J Immunol; 2014 Apr; 44(4):1130-6. PubMed ID: 24375473
[TBL] [Abstract][Full Text] [Related]
22. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
Arsenault RJ; Kogut MH; He H
Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
[TBL] [Abstract][Full Text] [Related]
23. RGS16 function is regulated by epidermal growth factor receptor-mediated tyrosine phosphorylation.
Derrien A; Druey KM
J Biol Chem; 2001 Dec; 276(51):48532-8. PubMed ID: 11602604
[TBL] [Abstract][Full Text] [Related]
24. Anti-WASP intrabodies inhibit inflammatory responses induced by Toll-like receptors 3, 7, and 9, in macrophages.
Sakuma C; Sato M; Oshima T; Takenouchi T; Chiba J; Kitani H
Biochem Biophys Res Commun; 2015 Feb; 458(1):28-33. PubMed ID: 25634698
[TBL] [Abstract][Full Text] [Related]
25. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
[TBL] [Abstract][Full Text] [Related]
26. STAT1 plays a role in TLR signal transduction and inflammatory responses.
Luu K; Greenhill CJ; Majoros A; Decker T; Jenkins BJ; Mansell A
Immunol Cell Biol; 2014 Oct; 92(9):761-9. PubMed ID: 25027037
[TBL] [Abstract][Full Text] [Related]
27. The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice.
Song IJ; Yang YM; Inokuchi-Shimizu S; Roh YS; Yang L; Seki E
Int J Cancer; 2018 Jan; 142(1):81-91. PubMed ID: 28875549
[TBL] [Abstract][Full Text] [Related]
28. Dysregulation of TLR9 in neonates leads to fatal inflammatory disease driven by IFN-γ.
Stanbery AG; Newman ZR; Barton GM
Proc Natl Acad Sci U S A; 2020 Feb; 117(6):3074-3082. PubMed ID: 31980536
[TBL] [Abstract][Full Text] [Related]
29. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
Wang Z; Wang M; Carr BI
J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308
[TBL] [Abstract][Full Text] [Related]
30. Endoplasmic Protein Nogo-B (RTN4-B) Interacts with GRAMD4 and Regulates TLR9-Mediated Innate Immune Responses.
Kimura T; Endo S; Inui M; Saitoh S; Miyake K; Takai T
J Immunol; 2015 Jun; 194(11):5426-36. PubMed ID: 25917084
[TBL] [Abstract][Full Text] [Related]
31. Recycling of EGFR and ErbB2 is associated with impaired Hrs tyrosine phosphorylation and decreased deubiquitination by AMSH.
Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2012 Nov; 24(11):1981-8. PubMed ID: 22800866
[TBL] [Abstract][Full Text] [Related]
32. The role of intermediary domain of MyD88 in cell activation and therapeutic inhibition of TLRs.
Avbelj M; Horvat S; Jerala R
J Immunol; 2011 Sep; 187(5):2394-404. PubMed ID: 21804016
[TBL] [Abstract][Full Text] [Related]
33. Cutting edge: a TLR9 cytoplasmic tyrosine motif is selectively required for proinflammatory cytokine production.
Chockalingam A; Rose WA; Hasan M; Ju CH; Leifer CA
J Immunol; 2012 Jan; 188(2):527-30. PubMed ID: 22174451
[TBL] [Abstract][Full Text] [Related]
34. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction.
Honda K; Ohba Y; Yanai H; Negishi H; Mizutani T; Takaoka A; Taya C; Taniguchi T
Nature; 2005 Apr; 434(7036):1035-40. PubMed ID: 15815647
[TBL] [Abstract][Full Text] [Related]
35. Functional outcome of B cell activation by chromatin immune complex engagement of the B cell receptor and TLR9.
Busconi L; Bauer JW; Tumang JR; Laws A; Perkins-Mesires K; Tabor AS; Lau C; Corley RB; Rothstein TL; Lund FE; Behrens TW; Marshak-Rothstein A
J Immunol; 2007 Dec; 179(11):7397-405. PubMed ID: 18025183
[TBL] [Abstract][Full Text] [Related]
36. Regulatory molecules required for nucleotide-sensing Toll-like receptors.
Saitoh S; Miyake K
Immunol Rev; 2009 Jan; 227(1):32-43. PubMed ID: 19120473
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection.
Tabeta K; Georgel P; Janssen E; Du X; Hoebe K; Crozat K; Mudd S; Shamel L; Sovath S; Goode J; Alexopoulou L; Flavell RA; Beutler B
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3516-21. PubMed ID: 14993594
[TBL] [Abstract][Full Text] [Related]
38. Pseudomonas aeruginosa stimulates tyrosine phosphorylation of and TLR5 association with the MUC1 cytoplasmic tail through EGFR activation.
Kato K; Lillehoj EP; Kim KC
Inflamm Res; 2016 Mar; 65(3):225-33. PubMed ID: 26645913
[TBL] [Abstract][Full Text] [Related]
39. Toll-like receptor-mediated tyrosine phosphorylation of paxillin via MyD88-dependent and -independent pathways.
Hazeki K; Masuda N; Funami K; Sukenobu N; Matsumoto M; Akira S; Takeda K; Seya T; Hazeki O
Eur J Immunol; 2003 Mar; 33(3):740-7. PubMed ID: 12616494
[TBL] [Abstract][Full Text] [Related]
40. Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation.
Iwata S; Yamaoka K; Niiro H; Nakano K; Wang SP; Akashi K; Tanaka Y
J Allergy Clin Immunol; 2012 Jun; 129(6):1594-601.e2. PubMed ID: 22541243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
